Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Scemblix
| Field | Information |
|---|---|
| Medication Name | Scemblix |
| Generic Name | Asciminib |
| Boxed/Label Warning | QTc Prolongation, Ischemic Cardiovascular Events, Occlusive Arterial Events, Pancreatitis, Embryo-Fetal Toxicity |
| Purpose | Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase |
| Mechanism of Action | Specifically targets the ABL myristoyl pocket (STAMP) of the BCR-ABL1 protein, inhibiting its activity |
| Dosage Forms | Oral tablets |
| Available Strengths | 20 mg, 40 mg |
| Dosage Frequency | Twice daily |
| Common Side Effects | Upper respiratory tract infections, musculoskeletal pain, fatigue, nausea, diarrhea, abdominal pain, rash, increased pancreatic enzymes |
| Serious Side Effects | QTc prolongation, ischemic cardiovascular events, occlusive arterial events, pancreatitis, embryo-fetal toxicity, myelosuppression, hypertension, hyperlipidemia |
| Drug Interactions | Strong CYP3A4 inhibitors (e.g., ketoconazole), strong CYP3A4 inducers (e.g., rifampin), sensitive CYP3A4 substrates, drugs that prolong the QTc interval |
| Important Notes | Monitor ECG for QTc prolongation. Monitor for cardiovascular events and pancreatitis. Women of reproductive potential should use effective contraception. |
| Storage | Store at room temperature, between 68°F to 77°F (20°C to 25°C). |
| Missed Dose | Take the missed dose as soon as you remember unless it is less than 6 hours until your next scheduled dose. Do not take two doses at the same time to make up for the missed dose. |
| Alternatives | Imatinib (Gleevec), Dasatinib (Sprycel), Nilotinib (Tasigna), Bosutinib (Bosulif) |
Scemblix Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Imatinib (Gleevec) | Tyrosine kinase inhibitor, inhibits BCR-ABL | First-generation TKI; effective but resistance can develop. |
| Dasatinib (Sprycel) | Tyrosine kinase inhibitor, inhibits BCR-ABL and other kinases | Second-generation TKI; more potent than Imatinib. |
| Nilotinib (Tasigna) | Tyrosine kinase inhibitor, inhibits BCR-ABL | Second-generation TKI; more potent than Imatinib. |
| Bosutinib (Bosulif) | Tyrosine kinase inhibitor, inhibits BCR-ABL and other kinases | Second-generation TKI; may have different side effect profile. |
Scemblix Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Upper respiratory tract infections | QTc prolongation |
| Musculoskeletal pain | Ischemic cardiovascular events |
| Fatigue | Occlusive arterial events |
| Nausea | Pancreatitis |
| Diarrhea | Myelosuppression (decreased blood cell counts) |
| Abdominal pain | Hypertension |
| Rash | Hyperlipidemia |
| Increased pancreatic enzymes | Embryo-Fetal Toxicity |
Scemblix Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Ph+ CML in Chronic Phase (Previously Treated) | 40 mg | 40 mg twice daily | Take orally with or without food. Swallow tablets whole; do not crush, cut, or chew. |
| Ph+ CML in Chronic Phase (Newly Diagnosed) | 80 mg | 80 mg twice daily | Take orally with or without food. Swallow tablets whole; do not crush, cut, or chew. |
Scemblix Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50 |
| Without Insurance (U.S.) | $22,900 |
| From CPS | $5,954 |
